FBO Notice Date 05/21/18
BIDS Reference Number 208
Document Type: Sources Sought
Instruments & Laboratory Equipment

Department of Veterans Affairs, VA Amarillo Health Care System, Department of Veterans Affairs Amarillo Health Care System, 79106

66 -- CTX Ventana Reagents SOL 36C25718Q0806 DUE 052918Ronalda Ohio

The Central Texas VA Health Care System (CTVHCS) is seeking Service Disabled Veteran Owned Small Business (SDVOSB) or Veteran Owned Small Business (VOSB) sources capable of meeting the requirement listed below. The acquisition will be accomplished using commercial item procedures in accordance with FAR Part 12.


The North American Industry Classification System (NAICS) is 325414. Any SDVOSB or VOSB firms who wish to identify their interests and capability to provide this product must provide product specifications, performance and delivery information by notifying the Contract Specialist no later than NOON PM Central Time, May 29, 2018. Notification shall be e-mailed to Ronalda Ohio, at ronalda.ohio@va.gov.


This Source Sought Notice is issued solely for information and planning purposes only and does not constitute a solicitation. All information received in response to this Notice that is marked as proprietary will be handled accordingly. In accordance with the Federal Acquisition Regulation, responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this Notice.



1. Title of Project: Ventana Immunohistochemical Reagents2. Scope of Work: The contractor shall provide all resources necessary to accomplish the deliverables described in this statement of work (SOW), except as may otherwise be specified. Contractor shall provide reagents and consumables for the Roche Ventana Benchmark Ultra Slide Staining System. 3. Background: In 2014 Central Texas Veterans Healthcare System purchased the Roche Ventana BenchMark Ultra Slide Staining System for specialized testing for cancer diagnosis. 4. Performance Period: Contract shall have a base with four (4), one (1) yearoptions to be exercised at the discretion of the Government.5. Type of Contract: This is a firm fixed-price contract.B. CONTRACT AWARD MEETINGThe contractor shall not commence performance on the tasks in this SOW until the CO has conducted a kick off meeting, or has advised the contractor that a kickoff meeting is waived.

C. GENERAL REQUIREMENTS 1. For every task, the contractor shall identify in writing all necessary subtasks (if any), associated costs by task, along with associated sub-milestone dates. The contractor's subtask structure shall be reflected in the technical proposal and detailed work plan.2. All written deliverables shall be phrased in layperson language. Statistical and other technical terminology shall not be used without providing a glossary of terms.D. SPECIFIC MANDATORY TASKS AND ASSOCIATED DELIVERABLES Description of Tasks and Associated Deliverables: The contractor shall provide the specific deliverables described in Attachment A within the performance period stated in Section A.4 of this SOW.E. SCHEDULE FOR DELIVERABLES1. The contractor shall complete the Delivery Date column in Attachment A for each deliverable specified.2. Unless otherwise specified, the number of draft copies and the number of final copies shall be the same.3. If for any reason any deliverable cannot be delivered within the scheduled time frame, the contractor is required to explain why in writing to the CO, including a firm commitment of when the work shall be completed.This notice to the CO shall cite the reasons for the delay, and the impact on the overall project. The CO will then review the facts and issue a response, in accordance with applicable regulations.F. CHANGES TO STATEMENT OF WORKAny changes to this SOW shall be authorized and approved only through written correspondence from the CO. A copy of each change will be kept in a project folder along with all other products of the project. Costs incurred by the contractor through the actions of parties other than the CO shall be borne by the contractor.G. CONFIDENTIALITY AND NONDISCLOSURE It is agreed that:1. The preliminary and final deliverables, and all associated working papers, application source code, and other material deemed relevant by VA which have been generated by the contractor in the performance of this task order, are the exclusive property of the U.S. Government and shall be submitted to the CO at the conclusion of the task order.2. The CO will be the sole authorized official to release, verbally or in writing, any data, draft deliverables, final deliverables, or any other written or printed materials pertaining to this task order. No information shall be released by the contractor. Any request for information relating to this task order, presented to the contractor, shall be submitted to the CO for response.3. Press releases, marketing material, or any other printed or electronic documentation related to this project, shall not be publicized without the written approval of the CO.Attachment A to the Statement of Work: Schedule of DeliverablesMaterial DescriptionQuantityMaterial DescriptionQuantityASSY, Kit Pack, Pathway C-Kit2CONFIRM Calretinin (SP65) RbmAb2AMPLIFICATION KIT, CE10CONFIRM CD8 (SP57) RabbitMono2Antibody Dilution Buffer (250ml)6CONFIRM Cytokeratin 20 Rabbit Mono5BLUING REAGENT40CONFIRM Cytokeratin7 RabbitMono5Hematoxylin II40CONFIRM EMA (E29) Mouse mAb3Label, Blank, Flap, 540 Roll35CONFIRM MART-1/melan A (A103)8OptiView Amplification Kit5Cytokeratin 5/6 (D5/16B4)3PROTEASE 115E Cadherin (EP700Y) PAb, Cell Marque1RIBBON, EBAR PRINTER4EP-CAM (Ber-EP4) PAb, Cell Marque5Ventana Antibody Diluent with Casein15GATA3 (L50-823) PAb, Cell Marque2Assy Temp Verifier Slides 10 pack6Hepatocyte Spc Ant(OCH1E5),2CONFIRM ANTI-KI-67 (30-9) RABBIT MONO2Napsin A (Polyclonal)4CINtec HISTOLOGY (250)4VENTANA anti-CD10 (SP67)2VENTANA H. PYLORI (SP48) PAB 25010VENTANA ANTI-CYCLIN D1 (SP4-R)1Anti-CEA (TF-3H8-1) PAB2VENTANA ANTI-P63 (4A4)5Anti-CHROMOGRANIN A (LK2H10) PAB5VENTANA Basal Cell Cktl (34BE12+p63)8anti-p40 (BC28) Mouse Monoclonal PAB3WT1 (6F-H2) PAb, Cell Marque1anti-p504s (SP116) Rabbit Monoclonal Pab40CONFIRM Neg. Contr. Rabbit Ig2ANTI-PAN KERATIN PRIMARY Ab,8NEGATIVE CONTROL MOUSE IG2CD56 (MRQ-42) PAb, Cell Marque4OptiView DAB Detection Kit 250 tests5CD-138 (B-A38) PAb, Cell Marque2ULTRAVIEW UNIVERSAL AP RED DET KIT20CDX-2 (EPR2764Y) PAb, Cell Marque3ultraView Universal DAB Detection Kit50CONFIRM anti MITF C5/D5 mouse mono3Prep Kit 1 (250), BM, BM XT, BM LT8CONFIRM ANTI-ACTIN MUSCLE (HUC1-1) PaB2Prep Kit 2 (250), BM, BM XT, BM LT8CONFIRM anti-CD3 (2GV6) Rabbit Monoclona4NEXES RGT DISPENSER CARD, Opt 115CONFIRM Anti-CD4 (SP35) Rabbit Mono2NEXES RGTT DISPENSER CARD, Opt 28CONFIRM anti-CD20 (L26) PAB410X EZ PREP SOLUTION, 2L40CONFIRM anti-CD34 (QBEnd/10) Primary5Benchmark ULTRA CC125CONFIRM anti-CD45 (LCA) (RP2/18) PAB4BenchMark Ultra LCS80CONFIRM anti-CD68 (KP-1) Primary Antibod2Reaction Buffer Concentrate (10X)60CONFIRM anti-Desmin (DE-R-11) PAb2Confirm Anti-PAX5 (SP34) Rabbit Mono3CONFIRM anti-Kappa Rabbit Polyclonal Pri1Confirm anti-CD5 (SP19) Rabbit Mono3CONFIRM anti-Keratin (34E12) Mouse Mono6BOTTLE, 20 LITER GRADUATED4CONFIRM anti-Lambda Rabbit Polyclonal Pr1ULTRA REAGENT TRAY AND CRADLE3CONFIRM anti-Melanosome (HMB45) Mouse8CONFIRM anti-S100 (polyclonal) PAB8CONFIRM anti-Synaptophysin (SP11) Rabbit4

CITE: https://www.fbo.gov/spg/VA/VAAHCS/VAAHCS/36C25718Q0806/listing.html